Experienced in Alopecia Areata

Dr. Alison Ehrlich

Dermatology
5530 Wisconsin Ave Ste 530, 
Chevy Chase, MD 
Experienced in Alopecia Areata
5530 Wisconsin Ave Ste 530, 
Chevy Chase, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Alison Ehrlich is a Dermatologist in Chevy Chase, Maryland. Dr. Ehrlich is rated as an Experienced provider by MediFind in the treatment of Alopecia Areata. Her top areas of expertise are Contact Dermatitis, Juvenile Dermatomyositis, Dermatomyositis, and Psoriasis.

Her clinical research consists of co-authoring 47 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Alopecia Areata.

Specialties
Dermatology
Licenses
Procedural Dermatology in MD
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

5530 Wisconsin Ave Ste 530, Chevy Chase, MD 20815

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: August 03, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects with Moderate to Severe Chronic Allergic Contact Dermatitis
A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects with Moderate to Severe Chronic Allergic Contact Dermatitis
Enrollment Status: Completed
Publish Date: November 14, 2024
Intervention Type: Drug
Study Drug: EB01 Cream
Study Phase: Phase 2
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
An Open-label, Single-Arm Pilot Study Investigating the Efficacy and Safety of Apremilast for the Treatment of Moderate to Severe Chronic Hand Dermatitis
An Open-label, Single-Arm Pilot Study Investigating the Efficacy and Safety of Apremilast for the Treatment of Moderate to Severe Chronic Hand Dermatitis
Enrollment Status: Withdrawn
Publish Date: January 11, 2023
Intervention Type: Drug
Study Phase: Phase 4
Photodynamic Therapy for Papulopustular Rosacea
Photodynamic Therapy for Papulopustular Rosacea
Enrollment Status: Completed
Publish Date: December 29, 2022
Intervention Type: Drug, Other, Device
Study Phase: Phase 4
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Other, Biological
Study Drugs: Lebrikizumab, Topical Corticosteroid
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 6 Less Clinical Trials

47 Total Publications

Nutritional Supplements and Cosmetic Formulations: A Review of Emerging Allergens.
Nutritional Supplements and Cosmetic Formulations: A Review of Emerging Allergens.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: October 16, 2025
Similar Doctors
Distinguished in Alopecia Areata
Dr. Valerie D. Callender
Dermatology
Distinguished in Alopecia Areata
Dr. Valerie D. Callender
Dermatology
12200 Annapolis Rd, 
Glenn Dale, MD 
 (15.3 miles away)
301-249-0970
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Valerie Callender is a Dermatologist in Glenn Dale, Maryland. Dr. Callender is rated as an Elite provider by MediFind in the treatment of Alopecia Areata. Her top areas of expertise are Acne, Melasma, Autosomal Recessive Hypotrichosis, and Contact Dermatitis. Dr. Callender is currently accepting new patients.

Distinguished in Alopecia Areata
Dr. Chesahna Kindred
Dermatology
Distinguished in Alopecia Areata
Dr. Chesahna Kindred
Dermatology
11125 Stratfield Ct, 
Marriottsville, MD 
 (26.7 miles away)
443-424-7754
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Chesahna Kindred is a Dermatologist in Marriottsville, Maryland. Dr. Kindred is rated as a Distinguished provider by MediFind in the treatment of Alopecia Areata. Her top areas of expertise are Alopecia Areata, Autosomal Recessive Hypotrichosis, GAPO Syndrome, and Pili Torti.

Distinguished in Alopecia Areata
Dr. Maral K. Skelsey
Dermatology
Distinguished in Alopecia Areata
Dr. Maral K. Skelsey
Dermatology

Dermatologic Surgery Center Of Washington, LLC

5530 Wisconsin Ave, Suite 820, 
Chevy Chase, MD 
 (1.4 miles away)
301-652-8081
Languages Spoken:
English, Armenian, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Maral Skelsey is a Dermatologist in Chevy Chase, Maryland. Dr. Skelsey is rated as a Distinguished provider by MediFind in the treatment of Alopecia Areata. Her top areas of expertise are Actinic Keratosis, Melanoma, Warts, and Seborrheic Keratosis. Dr. Skelsey is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ehrlich's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile